Literature DB >> 16959758

Early reperfusion phenomena.

Guy R Heyndrickx1.   

Abstract

Cycles of ischemia-reperfusion are ubiquitous in clinical cardiology. Depending on the duration and intensity of the ischemic episode as well as its repetition mode, several pathophysiologic syndromes have been identified, such as myocardial stunning, hibernation, and preconditioning. It remains a difficult exercise to distinguish ischemic from reperfusion damage. Production of oxygen free radicals and alteration in calcium homeostasis are major players during early reperfusion, responsible for the pathologic and functional alterations. At the molecular level, upregulation and downregulation of a number of genes have been observed in stunned myocardium, pointing toward some inborn survival adaptive mechanism. The no-reflow phenomenon, a most paradoxic event after reperfusion, usually occurs after more prolonged episodes of ischemia. The underlying mechanism involves additional lesions to the microvasculature interacting with myocytes lesions. Further insight into molecular and genomic adaptation to ischemia and reperfusion will undoubtedly help to improve our ability to fight reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959758     DOI: 10.1177/1089253206291137

Source DB:  PubMed          Journal:  Semin Cardiothorac Vasc Anesth        ISSN: 1089-2532


  5 in total

Review 1.  Pathophysiology and pathogenesis of post-resuscitation myocardial stunning.

Authors:  Athanasios Chalkias; Theodoros Xanthos
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

2.  c-Jun N-terminal kinase (JNK-1) confers protection against brief but not extended ischemia during acute myocardial infarction.

Authors:  Jianqin Wei; Weiwen Wang; Ines Chopra; Hui Fang Li; Christopher J Dougherty; Jennipher Adi; Nikhil Adi; Huilan Wang; Keith A Webster
Journal:  J Biol Chem       Date:  2011-02-15       Impact factor: 5.157

3.  Acute hemodynamic effects of angiotensin- converting enzyme inhibition after prolonged cardiac arrest with Bretschneider's solution.

Authors:  Alexandro Hoyer; Jörg Kempfert; Patrick Pritzwald-Stegmann; Friedrich-Wilhelm Mohr; Stefan Dhein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-10-12       Impact factor: 3.000

Review 4.  Toll-like receptor and its roles in myocardial ischemic/reperfusion injury.

Authors:  Yu Fang; Jianguo Hu
Journal:  Med Sci Monit       Date:  2011-04

5.  New insights into the role of peroxisome proliferator-activated receptors in regulating the inflammatory response after tissue injury.

Authors:  Miriam D Neher; Sebastian Weckbach; Markus S Huber-Lang; Philip F Stahel
Journal:  PPAR Res       Date:  2012-02-29       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.